Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Roche Introduces Digital Health Solutions Under Navify Brand

By LabMedica International staff writers
Posted on 08 Nov 2022

Roche (Basel, Switzerland) has announced that its digital health portfolio will now be available under the navify brand. The navify digital solutions help providers and patients 'navigate' and 'clarify' a wide range of touchpoints by activating insights that provide evidence on how to optimize operational processes and clinical decision making in healthcare.

Together, navify brings new ways to improve interoperability of digital infrastructure, use advanced analytics to deliver operational excellence, improved workflows, and patient-centric ways of working, and generate advanced medical insights that augment clinical decision support. The portfolio across Roche includes more than 30 digital solutions for labs, hospitals and patients worldwide and many key initiatives to advance digital transformation in healthcare. Several late stage pilots with customers and tech collaborators are underway for digital infrastructure (navify Core Integrator), operational excellence (navify Sample Tracking) and for medical insights (navify Screening for Cervical Cancer, navify Kidney Companion and navify Algorithm Suite).

With navify Marketplace, Roche connects labs and healthcare providers and third-party medtech and other companies to help bring innovations to healthcare. Several startups or companies are involved and more are joining: Smart4Diagnostics, imito (wound.app), decide Clinical Software (glucotab), Glytec, Precordior (CardioSignal), SteadySense (SteadyTemp), Deigma, TestCard, Etheclo, Tracie Healthcare Solutions and Binary Tech. Medial EarlySign, which develops AI-based clinical predictive analytics, is the latest to join, allowing for EarlySign ColonFlag to be accessible to labs and hospitals via the navify platform in the near future.

"Today we are using navify digital solutions, such as algorithms, and data science to deliver insights that are actionable in healthcare, building on three decades of software experience with diagnostics in laboratories," said Moritz Hartmann, Head of Roche Information Solutions. "We are creating open digital ecosystems with labs, hospitals and medtech companies to bring the latest innovations faster to society to better serve patients, and to support clinicians in providing care for patients. These activities support our strategy to deliver insights that drive personalised care."

Related Links:
Roche

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.